SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001640455-21-000066
Filing Date
2021-03-10
Accepted
2021-03-10 16:45:08
Documents
2

Document Format Files

Seq Description Document Type Size
1 424B5 jnce424b5-03102021final.htm 424B5 588504
2 jounce-tp2a.jpg GRAPHIC 61587
  Complete submission text file 0001640455-21-000066.txt   674412
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-223518 | Film No.: 21730416
SIC: 2836 Biological Products, (No Diagnostic Substances)